Three genes (FOXC1, EN1, and ELF5) stood out by displaying a pattern opposite to that of FOXA1, with hypomethylation and expression in Basal tumors, but hypermethylation and repressed expression in all other breast cancer subtypes (Supplementary Fig. S4s). This evidence concerns the gene FOXC1 and breast cancer.